| Mouse expressing a light chain containing a human lambda variable region and a … |
2023-8-03 |
2023-9-22 |
|
| Auto-injector |
2023-7-31 |
2023-8-17 |
|
| Humanized il-4 and il-4r animals |
2023-7-30 |
2023-9-01 |
|
| Non-human animals expressing exogenous terminal deoxynucleotidyltransferase |
2023-7-30 |
2023-9-01 |
|
| Bispecific anti-BCMA x anti-CD3 antibodies and their uses |
2023-7-19 |
2023-9-27 |
|
| Antigen-binding proteins that activate the leptin receptor |
2023-7-19 |
2023-8-31 |
|
| Methods for reducing cardiovascular risk |
2023-7-16 |
2023-9-01 |
|
| Tropism-modified recombinant viral particles and uses thereof for the targeted … |
2023-7-12 |
2023-8-03 |
|
| Method for treating or preventing asthma by administering an IL-4R antagonist |
2023-7-12 |
2023-10-03 |
|
| Methods of treating skin cancer by administering a PD-1 inhibitor |
2023-7-07 |
2023-9-05 |
|
| ANTI-CD8 ANTIBODY AND USES THEREOF |
2023-6-27 |
2023-8-31 |
|
| Anti-vegf protein compositions and methods for producing the same |
2023-6-23 |
2023-10-19 |
|
| Anti-CTLA-4 antibodies and uses thereof |
2023-6-09 |
2023-8-16 |
|
| Method and system of identifying and quantifying a protein |
2023-6-09 |
2023-10-05 |
|
| Non-human animal expressing humanized cd3 complex |
2023-6-01 |
2023-7-21 |
|
| Assembly line with built-in electronic visual inspection |
2023-5-25 |
2023-8-29 |
|
| Methods for treating allergy and enhancing allergen-specific immunotherapy by … |
2023-5-17 |
2023-7-26 |
|
| Methods and compositions for targeted genetic modification using paired guide … |
2023-5-15 |
2023-10-19 |
|
| Anti-CD3 antibodies, bispecific antigen-binding molecules that bind CD3 and … |
2023-5-12 |
2023-7-19 |
|
| Il2 agonists and methods of use thereof |
2023-5-09 |
2023-10-19 |
|
| Systems and methods for leveraging relatedness in genomic data analysis |
2023-5-08 |
2023-7-26 |
|
| Methods and systems for chromatography data analysis |
2023-5-08 |
2023-8-31 |
|
| Mice expressing a limited immunoglobulin light chain repertoire |
2023-5-04 |
2023-5-25 |
|
| Compositions and methods for detecting a biological contaminant |
2023-5-04 |
2023-9-21 |
|
| Dupilumab - extended SPC |
2023-5-02 |
2023-5-02 |
|
| Antigen-binding proteins that antagonize leptin receptor |
2023-5-02 |
2023-7-04 |
|
| Hydroxysteroid 17-beta dehydrogenase 13 (HSD17B13) variants and uses thereof |
2023-5-01 |
2023-5-25 |
|
| Non-human animals having humanized programmed cell death 1 gene |
2023-4-20 |
2023-6-15 |
|
| Human antibodies to middle east respiratory syndrome-coronavirus spike protein |
2023-4-04 |
2023-6-20 |
|
| Methods for breaking immunological tolerance using multiple guide rnas |
2023-4-03 |
2023-6-06 |
|
| Methods for treating atopic dermatitis by administering il-4r antagonist |
2023-3-29 |
2023-6-13 |
|
| Immunotherapeutic Agents For Patients Whose Tumors Carry A High Passenger Gene … |
2023-3-20 |
2023-8-24 |
|
| Antibodies against anti-sars-cov-2 spike glycoprotein and antigen-binding … |
2023-3-13 |
2023-8-25 |
|
| Multispecific antigen-binding molecules and uses thereof |
2023-3-07 |
2023-5-23 |
|
| Human antibodies to ebola virus glycoproteins |
2023-3-07 |
2023-5-12 |
|
| Human Antibodies to GREM1 |
2023-3-06 |
2023-6-22 |
|
| Formulation containing high concentration vegf receptor fusion protein |
2023-2-24 |
2023-5-23 |
|
| Methods and compositions for therapeutic protein delivery |
2023-2-22 |
2023-4-13 |
|
| common light chain mouse |
2023-2-21 |
2023-5-02 |
|
| Non-human animals having engineered immunoglobulin lambda light chain locus |
2023-2-17 |
2023-4-12 |
|
| EGFR x CD28 MULTISPECIFIC ANTIBODIES |
2023-2-07 |
2023-10-12 |
|
| Stable antibody formulation |
2023-2-01 |
2023-6-15 |
|
| Anti-tmprss2 antibodies and antigen-binding fragments |
2023-1-26 |
2023-8-24 |
|
| Mouse model of ditra disease and uses thereof |
2023-1-25 |
2023-6-08 |
|
| Dosing Strategy that Mitigates Cytokine Release Syndrome for Therapeutic … |
2023-1-25 |
2023-6-01 |
|
| Anti-PCSK9 inhibitory antibodies for treating patients with hyperlipidemia … |
2023-1-24 |
2023-3-16 |
|
| polymer protein microparticles |
2023-1-23 |
2023-4-11 |
|
| Methods for treating chronic sinusitis with nasal polyps by administering il-4r … |
2023-1-18 |
2023-4-11 |
|
| Methods for treating or preventing asthma by administering an IL-4R antagonist |
2023-1-18 |
2023-4-11 |
|
| Devices and methods for overfilling drug containers |
2023-1-13 |
2023-4-11 |
|
| Genetically modified non-human animals and methods of use thereof |
2023-1-09 |
2023-9-21 |
|
| Chimeric antigen receptors with specificity for bcma and their uses |
2022-12-28 |
2023-7-07 |
|
| Humanized rodents for testing therapeutic agents |
2022-12-27 |
2023-9-07 |
|
| Genetically modified t-cell receptor mice |
2022-12-26 |
2023-2-16 |
|
| Aseptic piercing system and method |
2022-12-23 |
2023-2-02 |
|
| Humanized non-human animals with restricted immunoglobulin heavy chain loci |
2022-12-22 |
2023-3-30 |
|
| Compositions and methods of manufacturing protein microparticles |
2022-12-22 |
2023-2-02 |
|
| Pharmaceutical compositions comprising macrolide diastereomers, methods of … |
2022-12-22 |
2023-10-12 |
|
| Taurine supplemented cell culture medium and methods of use |
2022-12-19 |
2023-2-02 |
|
| Methods for quantitating individual antibodies from a mixture |
2022-12-19 |
2023-4-20 |
|
| Fucosylation-deficient cells |
2022-12-15 |
2023-9-21 |
|
| Anti-human papillomavirus (hpv) antigen-binding proteins and methods of use … |
2022-12-15 |
2023-8-31 |
|
| Bispecific Anti-PSMA x Anti-CD28 Antibodies and Uses Thereof |
2022-12-07 |
2023-9-28 |
|
| Humanized rodents that express heavy chains containing vl domain |
2022-11-30 |
2023-1-26 |
|
| Anti-activin a antibodies and uses thereof |
2022-11-28 |
2023-10-05 |
|
| Non-human animals comprising a humanized ttr locus and methods of use |
2022-11-22 |
2023-3-16 |
|
| Lincrna-deficient non-human animals |
2022-11-16 |
2023-6-22 |
|
| Compositions and methods for making antibodies based on use of an expression- … |
2022-11-10 |
2023-10-12 |
|
| Humanized universal light chain mice |
2022-11-07 |
2023-1-24 |
|
| Transcription modulation in animals using crispr/cas systems |
2022-11-01 |
2023-4-20 |
|
| Human antibodies against s. aureus hemolysin a toxin |
2022-10-25 |
2023-1-24 |
|
| Non–human animals having a humanized signal–regulatory protein gene |
2022-10-24 |
2023-9-01 |
|
| Non-human animals having humanized fc-gamma receptors |
2022-10-17 |
2023-7-27 |
|
| Humanized il-15 animals |
2022-10-17 |
2023-6-22 |
|
| Human antibodies to the glucagon receptor |
2022-10-11 |
2023-6-22 |
|
| Heavy Chain Constant Regions with Reduced Binding to Fc Gamma Receptors |
2022-10-06 |
2023-9-14 |
|
| Readily isolable bispecific antibodies with native immunoglobulin format |
2022-9-30 |
2022-11-18 |
|
| Humanized light chain mice |
2022-9-29 |
2022-12-06 |
|
| Compositions and methods for making antibodies based on use of expression- … |
2022-9-28 |
2023-4-27 |
|
| Methods for enhancing efficacy of vaccine by administering il-4r antagonist |
2022-9-26 |
2022-12-13 |
|
| Anti-MUC16 Antibodies, Antibody-Drug Conjugates, and Bispecific Antigen-Binding … |
2022-9-26 |
2023-8-31 |
|
| Non-human animals having humanized cluster of differentiation 274 gene |
2022-9-20 |
2022-12-13 |
|
| Anti-c5 antibodies and uses thereof |
2022-9-19 |
2023-6-08 |
|
| Anti-lag3 antibodies and uses thereof |
2022-9-15 |
2022-11-22 |
|
| Serum-free cell culture medium |
2022-9-14 |
2022-11-15 |
|
| Methods for treating patients with familial hypercholesterolemia |
2022-9-14 |
2022-11-30 |
|
| Methods for treating or preventing atherosclerosis by administering inhibitor … |
2022-9-09 |
2022-11-30 |
|
| Anti-angptl3 antibodies and uses thereof |
2022-9-08 |
2022-12-22 |
|
| Multimeric protein purity determination |
2022-9-02 |
2022-11-11 |
|
| Humanized t cell mediated immune responses in non-human animals |
2022-8-26 |
2022-10-13 |
|
| Methods for preventing or treating allergy by administering an il-4r antagonist |
2022-8-26 |
2022-11-09 |
|
| GAN-CNN for MHC peptide binding prediction |
2022-8-26 |
2022-9-22 |
|
| How to treat inflammatory conditions |
2022-8-24 |
2023-9-27 |
2023-9-27 |
| Bispecific Anti-MUC16 x Anti-CD28 Antibodies and Uses Thereof |
2022-8-17 |
2023-9-07 |
|
| Anti-gitr antibodies and uses thereof |
2022-8-17 |
2022-10-17 |
|
| Maytansinoid derivatives, conjugates thereof, and methods of use |
2022-8-16 |
2023-4-13 |
|
| Efficient selectivity of recombinant proteins |
2022-8-04 |
2023-8-01 |
|
| Human antibodies to pd-1 |
2022-8-03 |
2022-10-19 |
|
| In situ raman spectroscopy systems and methods for controlling process … |
2022-8-03 |
2022-10-12 |
|
| Devices and methods for precision dose delivery |
2022-8-01 |
2022-11-24 |
|